Evidence map›Paper›PMID 42412915›Full record

ArticleScience signaling2026

Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ-mediated inflammatory death program.

Nicholas D Sun, Allison R Carr, Erica N Krogman, Yogesh Chawla, Jun Zhong, Matthew C Guttormson, Mark Chan, Michelle A Hsu, Haidong Dong, Dusan Bogunovic and 3 more

Abstract read
In one paragraph

Article in Science signaling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Nicholas D SunDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-0735-7956
Allison R CarrDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-1315-4215
Erica N KrogmanDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Yogesh ChawlaDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-6679-518X
Jun ZhongDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-3148-4143
Matthew C GuttormsonDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0009-0003-5643-8597
Mark ChanDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-9284-1680
Michelle A HsuDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-3214-2607
Haidong DongDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-5782-2983
Dusan BogunovicColumbia Center for Genetic Errors of Immunity, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0002-0683-6920
Akhilesh PandeyDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-9943-6127
Laura M RogersDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-0861-3269
Adrian T TingDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-0653-9923

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Regulation of TNF Receptor-mediated Cell DeathR01AI052417 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI TING, ADRIAN T · 2002 to 2020
$5.9M
Inborn Errors of Immunity Leading to Autoinflammatory SyndromesR01AI148963 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BOGUNOVIC, DUSAN · 2020 to 2024
$2.5M
Training Program in ImmunologyT32AI170478 · NIAID · MAYO CLINIC ROCHESTER · PI Virginia Smith Shapiro · 2022 to 2026
$1.4M
Regulation of TNF Receptor-Mediated ApoptosisR56AI052417 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TING, ADRIAN T · 2008 to 2008
$424k
Sensitization to RIPK1-dependent death as a strategy to enhance response of renal cell carcinoma (RCC) to immunotherapyR21CA270380 · NCI · MAYO CLINIC ROCHESTER · PI TING, ADRIAN T · 2023 to 2023
$415k
NCI NIH HHS P30 CA015083NCI NIH HHS R21 CA270380NIAID NIH HHS R01 AI052417NIAID NIH HHS R01 AI148963NIAID NIH HHS R56 AI052417NIAID NIH HHS T32 AI170478
6 · The paper itself

Abstract

Cytotoxic T cells produce the cytokine interferon-γ (IFN-γ). We sought to determine whether IFN-γ directly kills target cells and found that T cells used IFN-γ to kill murine melanoma cells lacking the kinases TBK1 and IKKε. In the absence of both kinases, IFN-γ induced the production of TNF receptor 1 (TNFR1) and the sensor Z-DNA binding protein 1 (ZBP1) in the tumor cells to stimulate receptor-interacting protein kinase 1 (RIPK1)-dependent apoptosis in a cell-autonomous manner. IFN-γ also enhanced the activation of nuclear factor κB (NF-κB) signaling in a TNFR1-dependent manner in cells deficient in both TBK1 and IKKε. Because IFN-γ-induced apoptosis occurred in a transcription-dependent manner with slow kinetics, STAT1 and NF-κB cooperated to activate the expression of inflammatory genes in the dying cells. Thus, IFN-γ-induced cell death was accompanied by an inflammatory signature in the absence of TBK1 and IKKε. TBK1 and IKKε not only mediated the induction of type I IFN but also inhibited RIPK1-dependent death and NF-κB-dependent inflammation. Therefore, we propose that these kinases may have gained these intertwined functions so that cells infected by pathogens that produce antagonists of TBK1 and IKKε are eliminated by IFN-γ-secreting T cells in an inflammatory manner to compensate for the inhibition of type I IFN production.

Indexed as

ApoptosisI-kappa B KinaseInterferon-gammaMelanoma, ExperimentalProtein Serine-Threonine KinasesT-Lymphocytes, CytotoxicAnimalsCell Line, TumorDNA-Binding ProteinsHumansInflammationMiceMice, KnockoutNF-kappa BReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type IDNA-Binding ProteinsI-kappa B KinaseIkbke protein, mouseInterferon-gammaNF-kappa BProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Tumor Necrosis Factor, Type IRipk1 protein, mouseRNA-Binding ProteinsStat1 protein, mouseSTAT1 Transcription FactorTbk1 protein, mouseTnfrsf1a protein, mouseZbp1 protein, mouse

Identifiers

PMID42412915
PMCPMC13674687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.